Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

An Indian Multi-centric Phase IV Study to Assess the Safety of Crizanlizumab in Sickle Cell Disease Patients

Novartis Pharmaceuticals · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
sickle-cell-disease
sickle cell disease (scd), sickle cell disease, sickle cell disorder, scd, sickle cell anemia, hemoglobin sc disease, sickling disorder due to hemoglobin s, vaso-occlusive crisis, voc, p-selectin, crizanlizumab, seg101
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 801253
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.